Last reviewed · How we verify
Malignant tumor of prostate
Approved treatments
- Xtandi · Astellas Pharma
Xtandi works by blocking the androgen receptor, a protein that helps prostate cancer cells grow. - Orgovyx · MYOVANT SCIENCES
Relugolix is a nonpeptide GnRH receptor antagonist that competitively binds to pituitary GnRH receptors. - Zytiga · Johnson & Johnson
Zytiga blocks the production of male hormones that fuel prostate cancer growth. - Erleada · Johnson & Johnson
Erleada blocks the androgen receptor, a protein that helps cancer cells grow. - Xofigo · Bayer
Xofigo works by emitting alpha particles that selectively target and kill cancer cells in the prostate. - Taxotere · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- MDV3100 · Pfizer Inc.
- Zytiga · Bukwang Pharmaceutical
- Docetaxol · Fudan University
- Xtandi · Astellas Pharma
Enzalutamide competitively inhibits androgen binding to androgen receptors, blocking nuclear translocation and DNA interaction. - Taxotere · Sanofi
Taxotere works by binding to microtubules, preventing them from disassembling and thereby blocking cell division. - Radium bromatum · Bayer Hlthcare
Radium bromatum works by emitting ionizing radiation that damages cancer cells, preventing them from growing and dividing. - Xofigo · Bayer
- Alpharadin · M.D. Anderson Cancer Center
Clinical guidelines
- FDA label — 2L
Docetaxel in combination with prednisone is indicated for the treatment of patients with metastatic castration-resistant prostate cancer.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Malignant tumor of prostate patent landscape — cliff calendar, originator estates, attackable patents
- Malignant tumor of prostate treatment landscape brief
- Malignant tumor of prostate treatment updates RSS
Frequently asked questions about Malignant tumor of prostate
What drugs treat Malignant tumor of prostate?
Tracked treatments include Xtandi, Orgovyx, Zytiga, Erleada, Xofigo, Taxotere, MDV3100, Docetaxol.
What is the treatment for Malignant tumor of prostate?
Standard treatment for Malignant tumor of prostate includes Xtandi, Orgovyx, Zytiga, Erleada, Xofigo. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Malignant tumor of prostate?
FDA label publishes guidelines for Malignant tumor of prostate. 1 guideline references tracked.
Related
- Treatment landscape: Malignant tumor of prostate patent cliff · Malignant tumor of prostate CI report
- Treatment: Xtandi · Astellas Pharma
- Treatment: Orgovyx · MYOVANT SCIENCES
- Treatment: Zytiga · Johnson & Johnson
- Treatment: Erleada · Johnson & Johnson
- Treatment: Xofigo · Bayer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing